Literature DB >> 16271739

Redefining the common insertion site.

Xiaolin Wu1, Brian T Luke, Shawn M Burgess.   

Abstract

Retroviral mutagenesis has been used as a powerful tool to discover genes involved in oncogenesis through a technique called Common Insertion Site (CIS) analysis where tumors are induced by proviral integrations and the genomic loci of the proviruses are identified. A fundamental assumption made in this analysis is that multiple proviral insertions in close proximity occurring more frequently than would be predicted randomly provides evidence that the genes near the integrations are involved in the formation of the tumors. We demonstrate here using data derived from MLV integrations not put under selection for tumor induction that CIS analysis as currently defined is often not a sufficient argument for a gene's significance in tumorigenesis.

Entities:  

Mesh:

Year:  2005        PMID: 16271739     DOI: 10.1016/j.virol.2005.08.047

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions.

Authors:  Dongmei Wang; Li-En Jao; Naizhong Zheng; Kyle Dolan; Jessica Ivey; Seth Zonies; Xiaolin Wu; Kangmai Wu; Hongbo Yang; Qingchao Meng; Zuoyan Zhu; Bo Zhang; Shuo Lin; Shawn M Burgess
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

2.  A largely random AAV integration profile after LPLD gene therapy.

Authors:  Christine Kaeppel; Stuart G Beattie; Raffaele Fronza; Richard van Logtenstein; Florence Salmon; Sabine Schmidt; Stephan Wolf; Ali Nowrouzi; Hanno Glimm; Christof von Kalle; Harald Petry; Daniel Gaudet; Manfred Schmidt
Journal:  Nat Med       Date:  2013-06-16       Impact factor: 53.440

3.  Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors.

Authors:  Jingqiong Hu; Gabriel Renaud; Theotonius J Gomes; Theotonius Golmes; Andrea Ferris; Paul C Hendrie; Robert E Donahue; Stephen H Hughes; Tyra G Wolfsberg; David W Russell; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2008-06-24       Impact factor: 11.454

4.  Derivation and characterization of bovine induced pluripotent stem cells by transposon-mediated reprogramming.

Authors:  Thirumala R Talluri; Dharmendra Kumar; Silke Glage; Wiebke Garrels; Zoltan Ivics; Katharina Debowski; Rüdiger Behr; Heiner Niemann; Wilfried A Kues
Journal:  Cell Reprogram       Date:  2015-04       Impact factor: 1.987

5.  Lentiviral Vectors with Cellular Promoters Correct Anemia and Lethal Bone Marrow Failure in a Mouse Model for Diamond-Blackfan Anemia.

Authors:  Shubhranshu Debnath; Pekka Jaako; Kavitha Siva; Michael Rothe; Jun Chen; Maria Dahl; H Bobby Gaspar; Johan Flygare; Axel Schambach; Stefan Karlsson
Journal:  Mol Ther       Date:  2017-04-20       Impact factor: 11.454

6.  DNA transposons: nature and applications in genomics.

Authors:  Martín Muñoz-López; José L García-Pérez
Journal:  Curr Genomics       Date:  2010-04       Impact factor: 2.236

Review 7.  Common integration sites for MMTV in viral induced mouse mammary tumors.

Authors:  Robert Callahan; Gilbert H Smith
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-08-15       Impact factor: 2.673

8.  Alphavirus production is inhibited in neurofibromin 1-deficient cells through activated RAS signalling.

Authors:  Olga A Kolokoltsova; Aaron M Domina; Andrey A Kolokoltsov; Robert A Davey; Scott C Weaver; Stanley J Watowich
Journal:  Virology       Date:  2008-05-15       Impact factor: 3.616

Review 9.  Cancer gene discovery in mouse and man.

Authors:  Jenny Mattison; Louise van der Weyden; Tim Hubbard; David J Adams
Journal:  Biochim Biophys Acta       Date:  2009-03-12

10.  Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.

Authors:  Barbara Felice; Claudia Cattoglio; Davide Cittaro; Anna Testa; Annarita Miccio; Giuliana Ferrari; Lucilla Luzi; Alessandra Recchia; Fulvio Mavilio
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.